Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
42,833,193
-
Total 13F shares
-
41,925,901
-
Share change
-
-752,840
-
Total reported value
-
$3,270,999,774
-
Put/Call ratio
-
123%
-
Price per share
-
$78.06
-
Number of holders
-
310
-
Value change
-
-$120,924,183
-
Number of buys
-
144
-
Number of sells
-
230
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2019
As of 30 Jun 2019,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
310 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,925,901 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, Palo Alto Investors LP, FIRST TRUST ADVISORS LP, AQR CAPITAL MANAGEMENT LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
310
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.